Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Peter C. Black, Joshua Griffin et al.|European Urology|2014Cited by 297
Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysisStephen B. Williams, Siamak Daneshmand, Marcus Cumberbatch et al.|European Urology|2020Cited by 127
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Homayoun Zargar et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient’s undergoing urologic oncology surgery: a systematic reviewNathan A. Brooks, Stephen B. Williams, Andrea Kokorovic et al.|World Journal of Urology|2020Cited by 43
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D‘Andrea, Shahrokh F. Shariat, Peter C. Black et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 23